Li Long, Nie Xiaoqi, Yi Minxiao, Qin Wan, Li Fang, Wu Bili, Yuan Xianglin
Department of Oncology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Front Oncol. 2020 Sep 15;10:528686. doi: 10.3389/fonc.2020.528686. eCollection 2020.
Radiation induced lung fibrosis (RILF) is a common late complication after radiotherapy without effective treatment. Thyroid hormone (TH) is known to reverse bleomycin-induced pulmonary fibrosis in recent study. We therefore sought to examine TH effect in RILF. Aerosolized TH delivery prevented pulmonary fibrosis according to either micro-computed tomography scans or histological evaluations, without significant changes in serum THs in a murine model of RILF by attenuating TGF-β1 and phosphorylated Smad2/3 expressions and reducing the accumulation of M2-like macrophages. Furthermore, hypothyroidism was significantly correlated with RILF in a retrospectively analyzed data from nasopharyngeal carcinoma patients treated by intensity-modulated radiation therapy with a median follow-up time of 25.5 months. Together, aerosolized TH may prevent RILF by inhibiting the TGF-β1/SMADs signaling pathway.
放射性肺纤维化(RILF)是放疗后常见的晚期并发症,目前尚无有效治疗方法。近期研究表明,甲状腺激素(TH)可逆转博来霉素诱导的肺纤维化。因此,我们试图研究TH在RILF中的作用。在RILF小鼠模型中,通过雾化吸入TH给药,根据微型计算机断层扫描或组织学评估,可预防肺纤维化,且血清THs无显著变化,这是通过减弱TGF-β1和磷酸化Smad2/3表达以及减少M2样巨噬细胞的积累实现的。此外,在一项对接受调强放疗的鼻咽癌患者进行回顾性分析的数据中,甲状腺功能减退与RILF显著相关,中位随访时间为25.5个月。总之,雾化吸入TH可能通过抑制TGF-β1/SMAD信号通路预防RILF。